Adalimumab for the treatment of ankylosing spondylitis
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.8.6.831
Reference51 articles.
1. Concepts and epidemiology of spondyloarthritis
2. ASAS/EULAR recommendations for the management of ankylosing spondylitis
3. Six months open label trial of leflunomide in active ankylosing spondylitis
4. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
5. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative real-world retention rate and safety of Biosimilar IBI303 versus Humira in Ankylosing Spondylitis;2024-07-29
2. Patient registry data on the efficacy and tolerability of adalimumab biosimilar in ankylosing spondylitis: A retrospective multicenter observational study;Arab Journal of Rheumatology;2023-07
3. Comparison of the efficacy and safety of biosimilar adalimumab injection with innovator adalimumab in subjects with active ankylosing spondylitis;2023-04-13
4. Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data;ACR Open Rheumatology;2019-08-12
5. Overcoming two technical pitfalls in MRI of paediatric and adolescent sacroiliitis;Clinical Radiology;2019-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3